KRAS(G12C) Can Either Promote or Impair Cap-Dependent Translation in Two Different Lung Adenocarcinoma Cell Lines

KRAS(G12C) is among the most common oncogenic mutations in lung adenocarcinoma and a promising target for treatment by small-molecule inhibitors. KRAS oncogenic signaling is responsible for modulation of tumor microenvironment, with translation factors being among the most prominent deregulated targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyriakopoulos, George, Katopodi, Vicky, Skeparnias, Ilias, Kaliatsi, Eleni G., Grafanaki, Katerina, Stathopoulos, Constantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926983/
https://www.ncbi.nlm.nih.gov/pubmed/33672357
http://dx.doi.org/10.3390/ijms22042222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926983/
https://www.ncbi.nlm.nih.gov/pubmed/33672357
http://dx.doi.org/10.3390/ijms22042222

Ejemplares similares